Market Place
Sourcing Support
Ipca Labs`s Generic Alendronate Sodium Receives Approval in US
04 Jun 2024 //
FDA
Novitium`s Generic Alendronate Sodium Receives Receives Approval in the U.S.
11 May 2023 //
FDA
New Data From Amgen`S Prolia® (Denosumab) Demonstrates Significant Reduction
08 May 2023 //
PR NEWSWIRE
Merck Beats Suits Tying Thighbone Fractures to Osteoporosis Drug
25 Mar 2022 //
BLOMMBERG LAW
Merck Fosamax case gets another shot at preemption argument
22 May 2019 //
FIERCE PHARMA
U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug
21 May 2019 //
YAHOO
Amgen sets $21,900 annual price for new Evenity bone drug
17 Apr 2019 //
ENDPTS
Once spurned, Amgen wins the FDA over with its osteoporosis drug Evenity
09 Apr 2019 //
ENDPTS
The Ripples Of The Fosamax Reversal
07 Mar 2019 //
DRUGANDDEVICE
List of Paragraph IV Patent Certifications Feb-12, 2019
13 Feb 2019 //
FDA
U.S. Supreme Court could side with Merck over Fosamax lawsuits
07 Jan 2019 //
REUTERS
Supreme Court to examine legal strategy drug makers use to sidestep lawsuits
04 Jan 2019 //
STAT NEWS
Binosto® Persistence and Efficacy Safety Data
26 Sep 2018 //
BUSINESSWIRE
List of New Paragraph IV Certifications as of Aug 21, 2018
21 Aug 2018 //
FDA
U.S. Supreme Court to hear Merck appeal over Fosamax suits
29 Jun 2018 //
REUTERS
Merck rebuts petition urging SCOTUS to ignore Fosamax appeal
13 Jun 2018 //
FIERCE PHARMA
Merck asks SCOTUS to restore FDA preemption shield
07 Dec 2017 //
FIERCE PHARMA
Justices Ask SG To Weigh In On Merck`s Fosamax MDL
04 Dec 2017 //
LAW360
The Third Circuit Fosamax Preemption Error Has Got To Go, Part 2
04 Oct 2017 //
DRUGDEVICELAW
Merck must face renewed Fosamax warning claims: U.S. appeals court
23 Mar 2017 //
REUTERS
Can Sprout`s Addyi shrug off serious side effects? These blockbusters did
27 Aug 2015 //
FIERCE PHARMA MARKETING
8 Invented Diseases Big Pharma Is Banking On
02 Feb 2015 //
ALTERNET
EMA Recommends Hundreds of Drugs to be Suspended Over "Flawed Studies"
24 Jan 2015 //
PHARMALOT
Supreme Court Declines to Review Case About Generic Labeling
21 Jan 2015 //
PHARMALOT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.